跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 3,032 条关于
“BSI (Netherlands)”
全部
3,032
临床试验
1,929
药物
493
机构
59
资讯
551
去年
LeukoStrat® CDx FLT3 Mutation Assay Receives EU Approval for AML Treatment Selection
5个月前
Invivoscribe Achieves IVDR Class C Certification for B-Cell Lymphoma Diagnostic Assay in Europe
7个月前
Biosion Initiates Phase 1 Trial of BSI-082 Anti-SIRPα Antibody for Advanced Solid Tumors
6个月前
GenScript Opens First European mRNA Production Facility in Netherlands
9个月前
Biocon Launches GLP-1 Liraglutide in Netherlands, Marking First EU Direct Brand Launch
9个月前
MRM Health Partners with Netherlands Cancer Institute to Develop Microbiome Therapies for Cancer Immunotherapy
9个月前
Quebec and Netherlands Reject Public Coverage of Alzheimer's Drug Lecanemab Despite Health Canada Approval
去年
ImmunoPrecise Antibodies Divests Netherlands Operations for $12M to Focus on AI-Driven Drug Discovery Platform
2年前
Lixte Biotechnology and Netherlands Cancer Institute Partner to Trial LB-100 in Metastatic Colon Cancer
去年
Syndax's Revuforj Approved for Leukemia, Biosion Inks $940M Antibody Deal with Aclaris
第 1 页,共 56 页
上一页
下一页